Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant

NCT02115126 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma
Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: LMP2A-loaded conventional DC vaccine
BIOLOGICAL: DUK-CPG-001

Sponsor

David Rizzieri, MD